Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2023 7
2024 5
2025 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for N. pilehvari
Your search for N. Pilevari retrieved no results
U.S. Military Tobacco and Nicotine Policy Lagging Behind the Times.
Lang AE, Porter KJ, Krukowski RA, Wester AG, Pilehvari A, Little MA. Lang AE, et al. Am J Prev Med. 2024 Feb;66(2):380-383. doi: 10.1016/j.amepre.2023.10.001. Epub 2023 Oct 7. Am J Prev Med. 2024. PMID: 37813172 Free PMC article. No abstract available.
Motives of Tobacco Use Among Young Adults in the United States Air Force.
Pebley K, Pilehvari A, Krukowski RA, Morris JD, Little MA. Pebley K, et al. Am J Health Promot. 2023 Jul;37(6):778-785. doi: 10.1177/08901171231156527. Epub 2023 Feb 7. Am J Health Promot. 2023. PMID: 36749676 Free PMC article.
SAMPLE: Air Force Airmen who used tobacco (N = 3243). MEASURES: Questions were about sociodemographic characteristics, tobacco use, and the Tobacco Motives Inventory (representing affect regulation, boredom, enhancement, and social motives). ...
SAMPLE: Air Force Airmen who used tobacco (N = 3243). MEASURES: Questions were about sociodemographic characteristics, tobacco use, a …
The Boosting Effects of Melatonin on the In Vitro Fertilization (IVF) of Women with Polycystic Ovary Syndrome.
Pilehvari S, Yavangui M, Paknahad E, Cheraghi Z, Ghorbani M. Pilehvari S, et al. Chonnam Med J. 2023 Sep;59(3):188-193. doi: 10.4068/cmj.2023.59.3.188. Epub 2023 Sep 25. Chonnam Med J. 2023. PMID: 37840679 Free PMC article.
In this clinical trial study, a total of 320 women with PCOS were randomly assigned to the intervention and control groups. Patients in the intervention group (n=160) received a combination of melatonin and metformin (3 mg and 500 mg, respectively) three times a day. The c …
In this clinical trial study, a total of 320 women with PCOS were randomly assigned to the intervention and control groups. Patients in the …
The value of ovarian hyperstimulation syndrome in predicting pregnancy outcome in women with polycystic ovarian syndrome and candidate for in vitro fertilization: A case-control study.
Pilehvari S, Radnia N, Ahmadiani S, Talebi-Ghane E, Alimohammadi N, Mousaei Tokaldani Z. Pilehvari S, et al. Int J Reprod Biomed. 2023 Dec 19;21(11):921-928. doi: 10.18502/ijrm.v21i11.14655. eCollection 2023 Nov. Int J Reprod Biomed. 2023. PMID: 38292512 Free PMC article.
The women were assigned to the case group (with OHSS, n = 129) and the control group (without OHSS, n = 51). Measuring the sexual hormones was performed using the enzyme-linked immunosorbent technique. ...
The women were assigned to the case group (with OHSS, n = 129) and the control group (without OHSS, n = 51). Measuring the sex …
Alterations of SOCS1 and SOCS3 transcript levels, but not promoter methylation levels in subcutaneous adipose tissues in obese women.
Emamgholipour S, Esmaeili F, Shabani M, Hasanpour SZ, Pilehvari M, Zabihi-Mahmoudabadi H, Motevasseli M, Shanaki M. Emamgholipour S, et al. BMC Endocr Disord. 2023 Jan 6;23(1):7. doi: 10.1186/s12902-022-01247-5. BMC Endocr Disord. 2023. PMID: 36609306 Free PMC article.
METHODS: This study was conducted on women with obesity (n = 24) [body mass index (BMI) 30 kg/m (2)] and women with normal-weight (n = 22) (BMI < 25 kg/m (2)). ...
METHODS: This study was conducted on women with obesity (n = 24) [body mass index (BMI) 30 kg/m (2)] and women with normal-weight ( …
Unveiling socioeconomic disparities in maternal smoking during pregnancy: a comprehensive analysis of rural and Appalachian areas in Virginia utilizing the multi-dimensional YOST index.
Pilehvari A, Chipoletti A, Krukowski R, Little M. Pilehvari A, et al. BMC Pregnancy Childbirth. 2024 Dec 19;24(1):828. doi: 10.1186/s12884-024-07032-7. BMC Pregnancy Childbirth. 2024. PMID: 39702043 Free PMC article.
RESULTS: Out of the overall sample, 92.8% (n = 7,292) were non-smokers, while 7.2% (n = 569) were smokers. The multi-level logistic regression analysis showed pregnant individuals aged 18-24 had 1.06 times higher odds of smoking compared to those over 35 (95% CI [1. …
RESULTS: Out of the overall sample, 92.8% (n = 7,292) were non-smokers, while 7.2% (n = 569) were smokers. The multi-level log …
Disparities in receipt of 1-st line CDK4/6 inhibitors with endocrine therapy for treatment of hormone receptor positive, HER2 negative metastatic breast cancer in the real-world setting.
Pilehvari A, Kimmick G, You W, Bonilla G, Anderson R. Pilehvari A, et al. Breast Cancer Res. 2024 Oct 18;26(1):144. doi: 10.1186/s13058-024-01902-w. Breast Cancer Res. 2024. PMID: 39425174 Free PMC article.

RESULTS: The study population included 3,917 patients receiving CDK4/6i plus ET (n = 2170) and ET alone (n = 1747) for their MBC. Compared to patients receiving ET alone, those receiving CDK4/6i plus ET were younger (mean age 66.8 vs. 68.6, p < 0.001), more likel

…
RESULTS: The study population included 3,917 patients receiving CDK4/6i plus ET (n = 2170) and ET alone (n = 1747) for their M …
Comparison Pregnancy Outcomes Between Minimal Stimulation Protocol and Conventional GnRH Antagonist Protocols in Poor Ovarian Responders.
Pilehvari S, ShahrokhTehraninejad E, Hosseinrashidi B, Keikhah F, Haghollahi F, Aziminekoo E. Pilehvari S, et al. J Family Reprod Health. 2016 Mar;10(1):35-42. J Family Reprod Health. 2016. PMID: 27385972 Free PMC article.
First group was the minimal stimulation group (n = 42) receiving 100 mg/day clomiphene citrate on day 2of the cycle for 5 day that was followed by150IU/day human menopausal gonadotropin (hMG) on day 5 of the cycle. Second group was the conventional group (n = 35) re …
First group was the minimal stimulation group (n = 42) receiving 100 mg/day clomiphene citrate on day 2of the cycle for 5 day that wa …
13 results